Circulating nucleic acids: An analysis of their occurrence in malignancies (Review)
- Authors:
- Shankar Suraj
- Chirag Dhar
- Sweta Srivastava
-
Affiliations: Department of Transfusion Medicine and Immunohematology, St. John's Medical College and Hospital, St. John's National Academy of Health Sciences, Bangalore, Karnataka 560034, India, St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, Karnataka 560034, India - Published online on: November 16, 2016 https://doi.org/10.3892/br.2016.812
- Pages: 8-14
This article is mentioned in:
Abstract
 |
|
Margolin G, Petrykowska HM, Jameel N, Bell DW, Young AC and Elnitski L: Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development. J Mol Diagn. 18:283–298. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
González-Masiá JA, García-Olmo D and García-Olmo DC: Circulating nucleic acids in plasma and serum (CNAPS): Applications in oncology. Onco Targets Ther. 6:819–832. 2013.PubMed/NCBI | |
|
Metais P and Mandel P: Les acides necleiques du plasma sanguin chez l'Homme. C R Acad Sci Paris. 142:241–243. 1948. | |
|
Fleischhacker M and Schmidt B: Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta. 1775:181–232. 2007.PubMed/NCBI | |
|
Crowley E, Di Nicolantonio F, Loupakis F and Alberto Bardelli A: Liquid biopsy: monitoring cancer-genetics in the blood. Nature Reviews Clinical Oncology. 10:472–484. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Schwarzenbach H, Hoon DS and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 11:426–437. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Stroun M, Lyautey J, Lederrey C, Olson-Sand A and Anker P: About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta. 313:139–142. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 46:318–322. 1989.PubMed/NCBI | |
|
García-Olmo DC, Ruiz-Piqueras R and García-Olmo D: Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: State of the issue. Histol Histopathol. 19:575–583. 2004.PubMed/NCBI | |
|
van der Vaart M and Pretorius PJ: Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci. 1137:18–26. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ and Huang DP: Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 59:1188–1191. 1999.PubMed/NCBI | |
|
Yang HJ, Liu VW, Tsang PC, Yip AM, Tam KF, Wong LC, Ng TY and Ngan HY: Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer. 14:903–910. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Anker P, Mulcahy H, Chen XQ and Stroun M: Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 18:65–73. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM and Sorenson GD: Cell-free DNA in human blood plasma: Length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 17:89–97. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Nagata S, Nagase H, Kawane K, Mukae N and Fukuyama H: Degradation of chromosomal DNA during apoptosis. Cell Death Differ. 10:108–116. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Holdenrieder S and Stieber P: Apoptotic markers in cancer. Clin Biochem. 37:605–617. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Nagata S: DNA degradation in development and programmed cell death. Annu Rev Immunol. 23:853–875. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M and Mueller MM: Cell-free plasma DNA: A marker for apoptosis during hemodialysis. Clin Chem. 52:523–526. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Fournié GJ, Courtin JP, Laval F, Chalé JJ, Pourrat JP, Pujazon MC, Lauque D and Carles P: Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 91:221–227. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Fadiel A, Naftolin F, Eichenbaum KD and Xia Y: Circulation DNA: Biological implications for cancer metastasis and immunology. Med Hypotheses. 65:956–961. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Anker P, Stroun M and Maurice PA: Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res. 35:2375–2382. 1975.PubMed/NCBI | |
|
Stroun M, Lyautey J, Lederrey C, Mulcahy HE and Anker P: Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: Evidence for a preferential release from viable cells? Ann N Y Acad Sci. 945:258–264. 2001.PubMed/NCBI | |
|
Alix-Panabières C, Schwarzenbach H and Pantel K: Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 63:199–215. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bidard FC, Weigelt B and Reis-Filho JS: Going with the flow: From circulating tumor cells to DNA. Sci Transl Med. 5:207ps14. 2013. | |
|
Ignatiadis M and Dawson SJ: Circulating tumor cells and circulating tumor DNA for precision medicine: Dream or reality? Ann Oncol. 25:2304–2313. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Roth C, Kasimir-Bauer S, Pantel K and Schwarzenbach H: Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol. 5:281–291. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Altimari A, Grigioni AD, Benedettini E, Gabusi E, Schiavina R, Martinelli A, Morselli-Labate AM, Martorana G, Grigioni WF and Fiorentino M: Diagnostic role of circulating free plasma DNA detection in patients with localized. Am J Clin Pathol. 129:756–762. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Schwarzenbach H: Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Res. 15:2112013. View Article : Google Scholar : PubMed/NCBI | |
|
Ono A, Fujimoto A, Yamamoto Y, Akamatsu S, Hiraga N, Imamura M, Kawaoka T, Tsuge M, Abe H, Hayes CN, et al: Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy. Cellular and Molecular Gastroenterology and Hepatology. 1:516–534. 2015. View Article : Google Scholar | |
|
Ho MW: Intercommunication via circulating nucleic acids. Science in Society. 42:46–48. 2009. | |
|
Gardiner C, Harrison P, Belting M, Böing A, Campello E, Carter BS, Collier ME, Coumans F, Ettelaie C, van Es N, et al: Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles. 4:269012015.PubMed/NCBI | |
|
Garcia-Murillas I, Schiavon G, Weigelt B, Ng C, Hrebien S, Cutts RJ, Cheang M, Osin P, Nerurkar A, Kozarewa I, et al: Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci Transl Med. 7:302ra133. 2015. | |
|
Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S and Hoon DS: Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 24:4270–4276. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hamakawa T, Kukita Y, Kurokawa Y, Miyazaki Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Taniguchi K and Takiguchi S: Monitoring gastric cancer progression with circulating tumour DNA. Br J Cancer. 112:352–356. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al: Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 6:224ra24. 2014. | |
|
Figg WD II and Reid J: Monitor tumor burden with circulating tumor DNA. Cancer Biol Ther. 14:697–698. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Roschewski M, Dunleavy K, Pittaluga S, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C, Chen CC, Zheng J, et al: Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma. Blood. 124:1392014. | |
|
De Mattos-Arruda L, Weigelt B, Cortes J, Won HH, Ng CKY, Nuciforo P, Bidard FC, Aura C, Saura C, Peg V, et al: Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle. Ann Oncol. 25:1729–1735. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Siravegna G and Bardelli A: Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance. Genome Biol. 15:4492014. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon KA, Park S, Lee SH, Kim JH and Lee JS: Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. J Mol Diagn. 11:182–185. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, et al: Circulating mutant DNA to assess tumor dynamics. Nat Med. 14:985–990. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
García-Olmo DC, Samos J, Picazo MG, Asensio AI, Toboso I and García-Olmo D: Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in rats. Cancer Lett. 272:133–140. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Frattini M, Gallino G, Signoroni S, Balestra D, Battaglia L, Sozzi G, Leo E, Pilotti S and Pierotti MA: Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. Ann N Y Acad Sci. 1075:185–190. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa A and Medeiros R: Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol. 27:415–421. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, et al: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 21:3902–3908. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Sai S, Ichikawa D, Tomita H, Ikoma D, Tani N, Ikoma H, Kikuchi S, Fujiwara H, Ueda Y and Otsuji E: Quantification of plasma cell-free DNA in patients with gastric cancer. Anticancer Res 27 (4C). 2747–2751. 2007. | |
|
Tomita H, Ichikawa D, Ikoma D, Sai S, Tani N, Ikoma H, Fujiwara H, Kikuchi S, Okamoto K, Ochiai T, et al: Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer. Anticancer Res 27 (4C). 2737–2741. 2007. | |
|
Atamaniuk J, Vidotto C, Tschan H, Bachl N, Stuhlmeier KM and Müller MM: Increased concentrations of cell-free plasma DNA after exhaustive exercise. Clin Chem. 50:1668–1670. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lo YM, Rainer TH, Chan LY, Hjelm NM and Cocks RA: Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 46:319–323. 2000.PubMed/NCBI | |
|
Jacobs EL and Haskell CM: Clinical use of tumor markers in oncology. Curr Probl Cancer. 15:299–360. 1991.PubMed/NCBI | |
|
Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW and Shih IeM: Increased plasma DNA integrity in cancer patients. Cancer Res. 63:3966–3968. 2003.PubMed/NCBI | |
|
Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ and Hoon DS: Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: Direct quantitative PCR for ALU repeats. Clin Chem. 52:1062–1069. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S and Hoon DS: Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 24:4270–4276. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Schwarzenbach H, Müller V, Stahmann N and Pantel K: Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer. Ann N Y Acad Sci. 1022:25–32. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Sunami E, Shinozaki M, Higano CS, Wollman R, Dorff TB, Tucker SJ, Martinez SR, Mizuno R, Singer FR and Hoon DS: Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem. 55:559–567. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB and Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59:67–70. 1999.PubMed/NCBI | |
|
Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM and Johnson PJ: Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59:71–73. 1999.PubMed/NCBI | |
|
Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, Gillet B, Gongora C, Dechelotte P and Robert B: Clinical validation of the detection of KRAS and BRAF. Nat Med. 20:430–435. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Etheridge A, Gomes CP, Pereira RW, Galas D and Wang K: The complexity, function and applications of RNA in circulation. Front Genet. 4:1152013.PubMed/NCBI | |
|
Dasí F, Lledó S, García-Granero E, Ripoll R, Marugán M, Tormo M, García-Conde J and Aliño SF: Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: A simple blood test to monitor disease in cancer patients. Lab Invest. 81:767–769. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Lledó SM, Garcia-Granero E, Dasí F, Ripoli R, García SA, Cervantes A and Aliño SF: Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Colorectal Dis. 6:236–242. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M, España P and Bonilla F: Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res. 7:2821–2825. 2001.PubMed/NCBI | |
|
Dasí F, Martínez-Rodes P, March JA, Santamaría J, Martínez-Javaloyas JM, Gil M and Aliño SF: Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer. Ann N Y Acad Sci. 1075:204–210. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kopreski MS, Benko FA, Kwak LW and Gocke CD: Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 5:1961–1965. 1999.PubMed/NCBI | |
|
Kopreski MS, Benko FA and Gocke CD: Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci. 945:172–178. 2001.PubMed/NCBI | |
|
Chinnappa P, Taguba L, Arciaga R, Faiman C, Siperstein A, Mehta AE, Reddy SK, Nasr C and Gupta MK: Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: Sensitive and specific markers for thyroid cancer. J Clin Endocrinol Metab. 89:3705–3709. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Turchinovich A, Weiz L and Burwinkel B: Isolation of circulating microRNA associated with RNA-binding protein. Methods Mol Biol. 1024:97–107. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Iorio MV and Croce CM: MicroRNAs in cancer: Small molecules with a huge impact. J Clin Oncol. 27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yu M: Somatic mitochondrial DNA mutations in human cancers. Adv Clin Chem. 57:99–138. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, Rainer TH and Lo YM: Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem. 49:719–726. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Copeland WC, Wachsman JT, Johnson FM and Penta JS: Mitochondrial DNA alterations in cancer. Cancer Invest. 20:557–569. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Campitelli M, Jeannot E, Peter M, Lappartient E, Saada S, de la Rochefordière A, Fourchotte V, Alran S, Petrow P, Cottu P, et al: Human papillomavirus mutational insertion: Specific marker of circulating tumor DNA in cervical cancer patients. PLoS One. 7:e433932012. View Article : Google Scholar : PubMed/NCBI | |
|
van der Vaart M and Pretorius PJ: The origin of circulating free DNA. Clin Chem. 53:22152007. View Article : Google Scholar : PubMed/NCBI | |
|
Vinay DS, Ryan EP, Pawelec G, et al: Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 35:S185–S198. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zou W: Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 6:295–307. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Johnsen AK, Templeton DJ, Sy M and Harding CV: Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol. 163:4224–4231. 1999.PubMed/NCBI | |
|
Gabrilovich D: Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol. 4:941–952. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Dunn GP, Bruce AT, Ikeda H, Old LJ and Schreiber RD: Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol. 3:991–998. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Lauritzsen GF, Hofgaard PO, Schenck K and Bogen B: Clonal deletion of thymocytes as a tumor escape mechanism. Int J Cancer. 78:216–222. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Enninga EA, Nevala WK, Holtan SG and Markovic SN: Immune reactivation by cell-free fetal DNA in healthy pregnancies re-purposed to target tumors: Novel checkpoint inhibition in cancer therapeutics. Front Immunol. 6:4242015.PubMed/NCBI | |
|
Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA and Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:546–549. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, et al: TLR3 deficiency in patients with herpes simplex encephalitis. Science. 317:1522–1527. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wölfle SJ, Strebovsky J, Bartz H, Sähr A, Arnold C, Kaiser C, Dalpke AH and Heeg K: PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol. 41:413–424. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Place RF, Li LC, Pookot D, Noonan EJ and Dahiya R: MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA. 105:1608–1613. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
García-Olmo DC, Domínguez C, García-Arranz M, Anker P, Stroun M, García-Verdugo JM and García-Olmo D: Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res. 70:560–567. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Mittra I, Khare NK, Raghuram GV, Chaubal R, Khambatti F, Gupta D, Gaikwad A, Prasannan P, Singh A, Iyer A, et al: Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosci. 40:91–111. 2015. View Article : Google Scholar : PubMed/NCBI |
